Relapse Risk Up With Antidepressant Therapy Discontinuation
Relapse occurred in fewer patients who maintained their antidepressant treatment versus those with discontinuation
Depression
Insulin Resistance Linked to Risk for Major Depressive Disorder
Three surrogate measures of insulin resistance linked to increased risk for incident major depression
Transcranial Magnetic Stimulation Device Cleared for Anxious Depression
The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.
Study Shows Loneliness Tied to Use of High-Risk Medications
The study authors utilized the National Social Life, Health, and Aging Project leave-behind questionnaire to obtain data on a total of 6017 adults over 65 years of age.
Antidepressant Use May Aid Outcomes in Depression and Diabetes
Regular vs poor antidepressant use tied to lower risk for advanced diabetic complications, mortality in patients with depression and diabetes
Prescription Digital Therapeutic for Anxiety, Depression Treatment Launched
Ensemble is an AI-powered digital mental health coach app designed to address the symptoms of MDD or GAD.
Zuranolone Bests Placebo in Postpartum Depression
At day 15, significantly greater reduction seen in depressive symptoms as measured by change in HAMD-17 score from baseline
Short-Course Zuranolone Looks Promising for MDD Treatment
Zuranolone is an investigational 2-week, once-daily oral treatment for adults with major depressive disorder.
Inhaled Nitrous Oxide Explored for Treatment-Resistant Depression
In phase 2 trial, 25% nitrous oxide comparable to 50% nitrous oxide for reducing symptoms, but with fewer adverse effects
Lumateperone Under Review for Bipolar Depression
The sNDA submissions are supported by data from 2 global randomized, double-blind, placebo-controlled phase 3 studies.
